This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Along with its global aesthetic business, Solta Medical, today announced the successful completion of the acquisition of Wuhan Shibo Zhenmei Technology Co., Ltd., consisting of the Shibo group's aesthetics distribution business. The Shibo group has served as Solta Medical's trusted distribution partner over the past decade. Effective December 1, 2025, Wuhan Shibo Zhenmei Technology Co., Ltd. became a wholly owned subsidiary of Solta Medical in China, assuming full responsibility for the distribution of Solta Medical's products, including Thermage® FLX, as well as other aesthetic devices in the Chinese market. Bausch Health Companies Inc. shares T.BHC are trading up $0.94 at $9.82.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).